AUTHORS : Duché Daniel Ferraris C Labrie Fernand Leclaire J Luu-The Van Meunier Jean-Roch MODELS : EPISKIN APPLICATIONS : SKIN METABOLISM Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models EpiskinTM and full thickness model from EpiskinTM 2009 Elsevier Journal of Steroid Biochemistry and Molecular Biology | L'Oréal, Episkin, SkinEthic
AUTHORS : Duché Daniel Ferraris C Labrie Fernand Leclaire J Luu-The Van Meunier Jean-Roch MODELS : EPISKIN APPLICATIONS : SKIN METABOLISM Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models Episkin and full thickness model from Episkin. 2009 J Steroid Biochem Mol Biol. 2009 Sep;116(3-5):178-86 | L'Oréal, Research & Innovation
AUTHORS : Castiel Higounenc I Ferraris C Gaetani Q Lavalle A Philippe M Schmidt R Augmentation du contenu en ceramides des epidermes humains reconstruits apres traitement avec un sphingolipide exogene a base sphinganine 2000 Experimental dermatology 2000 ;18 (8):541-546 | L'OREAL - Life Sciences Advances Research, Centre Charles Zviak - 90, rue du General Roguet, 92583 Clichy, France
AUTHORS : Castiel Higounenc I Ferraris C Gaetani Q Lavalle A Philippe M Schmidt L'Oreal R MODELS : EPISKIN Exogenous sphinganin derived sphingolipid increases epidermal ceramide content in human reconstructed skin 1999 Nouvelles Dermatologiques 1999 ;18 (8):541-546 | I. Castiel-Higounenc, Life Sci. Adv. Res. Ctr. C. Zviak, 90, rue du General Roguet, 92583 Clichy Cedex